Profiler

Kenneth M. Merz Jr.

Staff, Lerner Research Institute; Professor, Michigan State University

Verifisert e-postadresse på msu.edu

Sitert av 201744

Computational Chemistry and Biology Modeling Quantum Chemistry Structure Based Design Chemistry

Andrew Leach

Head of Chemical Biology, European Bioinformatics Institute

Verifisert e-postadresse på ebi.ac.uk

Sitert av 33691

drug discovery computational chemistry cheminformatics structure-based design EMBL-EBI-Research-Group

Richard D Taylor

Director, CADD, UCB

Verifisert e-postadresse på ucb.com

Sitert av 9315

Drug Discovery Small Molecule Modelling Antibody Modelling Structure-Based Design Computational Modelling

Charles H. Reynolds

Gfree Bio LLC, Ansaris, Rohm and Haas, Johnson & Johnson

Verifisert e-postadresse på gfreebio.com

Sitert av 5972

modeling structure-based design computational chemistry

Ying-Duo Gao

Structural Chemistry, Merck & Co., Inc.

Verifisert e-postadresse på merck.com

Sitert av 3094

Structure-based design ADME modeling QSAR

Daniel L. Cheney

Scientific Director BMS (Retired 2023)

Sitert av 2844

Drug Discovery Structure-Based Design Applied Quantum Chemistry

Bernard Pirard

Investigator III, Novartis

Verifisert e-postadresse på novartis.com

Sitert av 1687

computer-aided drug design molecular modeling structure-based design fragment-based design medicinal chemistry

Andy Mason

GSK

Verifisert e-postadresse på gsk.com

Sitert av 1621

Medicinal chemistry AI-machine learning Peptides PROTACTS Structure based design

Santosh Khedkar

Founder & President, ChemBio Discovery, Inc.

Verifisert e-postadresse på chembiodiscovery.com

Sitert av 1602

Computational Chemistry Structure-based design Docking & Binding affinity Lead discovery & optimization Antibody & ADC

Chaya Duraiswami

Product Director (Safety & Efficacy), Glaxosmithkline

Verifisert e-postadresse på gsk.com

Sitert av 1553

Drug design/development Cheminformatics Structure-based design ADME-Tox Modelling Machine Learning

1 - 10